Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Related Articles
Commentaries
MAKE A COMMENT
All fields required
More Views
- Cuba loses a paradigm of forensic medicine and science: Dr. Jorge González Pérez, Popi, has passed away
- Trump’s pick to lead U.S. military has tattoos linked to white supremacists and Nazis
- World Bank reports Israel’s aggression inflicts $8.5 billion in economic losses on Lebanon
- United States votes against UN resolution in favor of the Palestinian people to self-determination
- Report reveals more journalists killed by Israel in Gaza than in any conflict in recent decades
